Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Operating Expenses | 7,997 | 5,111 | 2,773 | 1,715 | 2,417 |
| Operating Income | -7,997 | -5,111 | -2,773 | -1,715 | -2,417 |
| Other Income | -879 | 0 | 0 | 0 | 75 |
| Pre-tax Income | -8,876 | -5,111 | -2,773 | -1,715 | -2,342 |
| Net Income Continuous | -8,876 | -5,111 | -2,773 | -1,715 | -2,342 |
| Net Income | $-8,876 | $-5,111 | $-2,773 | $-1,715 | $-2,342 |
| EPS Basic Total Ops | -1.81 | -1.37 | -0.74 | -0.49 | -0.72 |
| EPS Basic Continuous Ops | -2.02 | -1.37 | -0.74 | -0.49 | -0.72 |
| EPS Diluted Total Ops | -1.81 | -1.37 | -0.74 | -0.49 | -0.72 |
| EPS Diluted Continuous Ops | -2.02 | -1.37 | -0.74 | -0.49 | -0.72 |
| EBITDA(a) | $-6,976 | $-5,109 | $-2,772 | $-1,715 | $-2,417 |